More articles from Commentary

You have access
Understanding and Setting Endotoxin Limits
Marlys E. Weary

PDA Journal of Pharmaceutical Science and Technology January 1990, 44 (1) 16-18;
You have access
Variability in the LAL Test
Karen Zink McCullough

PDA Journal of Pharmaceutical Science and Technology January 1990, 44 (1) 19-21;
You have access
FDA Regulations and Guidelines
Albert Rothschild

PDA Journal of Pharmaceutical Science and Technology January 1990, 44 (1) 26-29;
You have access
Highlights of Good Manufacturing Practice in Japan
Kazuyuki Morita

PDA Journal of Pharmaceutical Science and Technology January 1990, 44 (1) 35-38;
You have access
Sterility Assurance Based on Validation of the Sterilization Process Using Steam Under Pressure
PDA Journal of Pharmaceutical Science and Technology September 1989, 43 (5) 226-230;
You have access
Preservative Efficacy: Compendial and Regulatory Issues
Murray S. Cooper

PDA Journal of Pharmaceutical Science and Technology July 1989, 43 (4) 187-190;
You have access
The Parenteral Drug Association Foundation for Pharmaceutical Sciences: Past, Present, and Future
Nathan C. Kirsch

PDA Journal of Pharmaceutical Science and Technology July 1989, 43 (4) 191-194;
You have access
Public Statement on Advancing Biomedical Technology
Frank E. Young

PDA Journal of Pharmaceutical Science and Technology July 1989, 43 (4) 194-196;
You have access
Regulatory Requirements for Supplemental Applications: The “Grey” Area
Gordon R. Personeus

PDA Journal of Pharmaceutical Science and Technology May 1989, 43 (3) 114-116;
You have access
Aluminum in Parenteral Products: LVP and SVP. FDA Medical Perspective
John C. Kenealy

PDA Journal of Pharmaceutical Science and Technology May 1989, 43 (3) 125-126;

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.